Genprex moves closer to clinical testing of its diabetes gene therapy through a new manufacturing partnership, amid ongoing efforts to build its pipeline despite high investor caution. Genprex has moved a step closer to advancing its diabetes gene therapy programme…
Primary care physician Lucy McBride emphasises that GLP-1 drugs are most effective when integrated into comprehensive treatment plans, extending their promise beyond weight loss to potentially reduce alcohol cravings and support behavioural change. GLP-1 medicines are best understood as part…
Medical authorities warn that the body’s natural systems are sufficient for waste removal, challenging the health claims of commercial detox programmes and highlighting safety concerns associated with unnecessary cleansing practices. Specialists say the body already has built-in systems for removing…
Amylyx Pharmaceuticals’ stock jumped 21% in pre-market trading following positive Phase 3 trial results for its experimental drug avexitide, signalling potential breakthrough in post-bariatric hypoglycaemia treatment. Amylyx Pharmaceuticals shares jumped in pre-market trading on Tuesday after the company said avexitide,…
A Swedish nationwide study reveals that patients with acromegaly-related diabetes face a significantly higher cardiovascular burden than those with type 2 diabetes alone, highlighting the need for targeted risk management. People with acromegaly-associated diabetes appear to face a heavier cardiovascular…
Researchers clarify their dosing strategies in a study examining semaglutide’s effects on osteoblast ferroptosis, addressing criticisms over dosage relevance and pathway analysis, and emphasising its mechanistic focus. Researchers behind a study on semaglutide and diabetic periodontitis have pushed back against…
Turkish health authorities highlight the growing health concerns associated with high-fructose corn syrup and starch-based sugars, urging for better labels and reduced intake, especially among children and at-risk groups. Turkish health official İlhan Satman has warned that heavy consumption of…
Two inflammation-based blood markers, SII and SIRI, may help identify women at higher risk of gestational diabetes, though current evidence is limited and more research is needed before they can be used routinely in clinical practice. New research suggests two…
The diabetic kidney disease sector is projected to reach $3.76 billion by 2030, driven by advancements in personalised medicine, early screening, and artificial intelligence, reshaping preventative care practices. The diabetic kidney disease market is expected to keep expanding steadily through…
A Chinese multicentre trial reveals that using glycated albumin to guide early treatment of newly diagnosed type 2 diabetes does not improve HbA1c target achievement but enhances metabolic control and could influence treatment strategies. A multicentre randomised trial in China…
